About Nephrocare
Nephrocare is a company based in Kolkata (India) founded in 2014 by Pratim Sengupta. Nephrocare has raised $972.08 thousand across 1 funding round from investors including Unizon, Winner Impex and Deepak Parekh. Nephrocare offers products and services including Kidney Transplantation and Dialysis Service.
- Headquarter Kolkata, India
- Founders Pratim Sengupta
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nephro Care India Limited
-
Annual Revenue
$2.2 M (USD)432.88as on Mar 31, 2023
-
Net Profit
$285.26 K (USD)530.58as on Mar 31, 2023
-
EBITDA
$360.66 K (USD)8349.75as on Mar 31, 2023
-
Total Equity Funding
$972.08 K (USD)
in 1 rounds
-
Latest Funding Round
$972.08 K (USD), Seed
Nov 12, 2023
-
Investors
Unizon
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Nephrocare
Nephrocare is a publicly listed company on the NSE with ticker symbol NEPHROCARE in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Nephrocare
Nephrocare offers a comprehensive portfolio of products and services, including Kidney Transplantation and Dialysis Service.
Kidney transplantation services are offered as part of renal care to address end-stage kidney diseases
Dialysis services are provided for patients with kidney failure, including options for home-based delivery
Funding Insights of Nephrocare
Nephrocare has successfully raised a total of $972.08K through 1 strategic funding round. The most recent funding activity was a Seed round of $972.08 thousand completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nephrocare
Nephrocare has secured backing from 11 investors, including angel and institutional investors. Prominent investors backing the company include Unizon, Winner Impex and Deepak Parekh.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Alternative investments in unlisted shares are enabled for individuals.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Nephrocare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nephrocare
Investment portfolio details for Nephrocare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nephrocare
Detailed financials for Nephrocare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nephrocare Comparisons
Peer comparison for Nephrocare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nephrocare
Detailed competitors of Nephrocare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nephrocare
Complete news archive for Nephrocare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nephrocare
Nephrocare was founded in 2014 and raised its 1st funding round 9 years after it was founded.
Nephrocare is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.
Somnath Chakraborty is the current CEO of Nephrocare.
Nephrocare is a funded company, having raised a total of $972.08K across 1 funding round to date.
Annual revenue of Nephrocare is $2.2M as on Mar 31, 2023.
Nephrocare was established in 2014 in Kolkata, India, as a standalone hospital in the nephrology sector. Kidney diseases are treated through various services, including advanced radiology, transplantation procedures, home dialysis options, clinical nutrition, lifestyle education, rehabilitation programs, and diagnostics. Operations focus on comprehensive care for renal patients in the region.
Nephrocare offers Kidney Transplantation and Dialysis Service.
Yes, Nephrocare is publicly traded on NSE under the ticker symbol NEPHROCARE.
Nephrocare has 11 investors. Key investors include Unizon, Winner Impex, Deepak Parekh, Bharat Dhirajlal Shah, and Rajendra Agarwal.
The ticker symbol of Nephrocare is NEPHROCARE on NSE.
The valuation of Nephrocare is $6.08M as of Nov 2023.